Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-14

Clinical Trial Update: Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating risperidone plus a mood stabilizer for treating mixed mania in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mood stabilizer (unspecified)
  • RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED